Common high blood pressure drugs do not increase the risk of contracting COVID-19 or developing severe symptoms, according to a US study.
The study of 12,594 patients, led by researchers from NYU Grossman School of Medicine, was published online in the New England Journal of Medicine.
The study found no links between treatment and increased likelihood of a positive test for COVID-19 or increased risk for more severe illness.
The four drug classes studied were angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), beta blockers, and calcium channel blockers.
The analysis compared treated and untreated patients, and a medical history was extracted for each identified patient with COVID-19 test results.
Lead investigator Dr Harmony Reynolds, associate director of the Cardiovascular Clinical Research Center at NYU Langone Health, said the findings should reassure the medical community and patients about the continued use of these commonly prescribed medications.
>> Read the original article here
Source: Science Daily
